News & Updates
Filter by Specialty:
AChEIs and memantine cost-effective, offer improvements in AD
A systematic review and meta-analysis of Alzheimer’s disease (AD) therapies’ cost-effectiveness carried out by researchers from the Chinese University of Hong Kong (CUHK) identifies acetylcholinesterase inhibitors (AChEIs) and memantine as cost-effective and offering improvements in dementia-related symptoms.
AChEIs and memantine cost-effective, offer improvements in AD
09 May 2022
Platelet function a potential biomarker of Alzheimer’s disease
A higher platelet response in middle-aged individuals who are free of antiplatelet therapy carries an increased risk of dementia in late life, according to a cohort study with 20 years of follow up.
Platelet function a potential biomarker of Alzheimer’s disease
07 May 2022
Physical activity associated with intact cognition after mild or moderate stroke
A Swedish register-based study finds that patients who engage in light or moderate physical activity are more likely to retain their cognitive function after a mild or moderate stroke vs inactive counterparts.
Physical activity associated with intact cognition after mild or moderate stroke
07 May 2022
Healthy lifestyle prolongs life, may prevent dementia onset
A healthy lifestyle among older men and women leads to a longer life expectancy, with freedom from Alzheimer’s dementia (AD) in their remaining years, a study has shown.
Healthy lifestyle prolongs life, may prevent dementia onset
28 Apr 2022
One in 10 patients fully recover from consciousness disorders after severe COVID-19
Among patients who suffer from disorders of consciousness (DoC) after severe COVID-19, around 10 percent can achieve functional independence after 1 year, reports a study presented at the recently concluded 2022 Annual Meeting of the American Academy of Neurology (AAN 2022).